While the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal cancers ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...